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ifurcation Coronary Lesions
reated With the “Crush” Technique
n Intravascular Ultrasound Analysis
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lexandra J. Lansky, MD, FACC,* Issam Moussa, MD, FACC,* Kenichi Fujii, MD,*
ideo Takebayashi, MD,* Takenori Yasuda, MD,* Jose R. Costa, JR, MD,* Yoshihiro Tsuchiya, MD,*
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dward M. Kreps, MD, FACC,* Antonio Colombo, MD, FACC,§ Gregg W. Stone, MD, FACC,*
artin B. Leon, MD, FACC,* Jeffrey W. Moses, MD, FACC*
ew York, New York; Odense, Denmark; and Milan, Italy
OBJECTIVES We report intravascular ultrasound (IVUS) findings after crush-stenting of bifurcation
lesions.
BACKGROUND Preliminary results with the crush-stent technique are encouraging; however, isolated reports
suggest that restenosis at the side branch (SB) ostium continues to be a problem.
METHODS Forty patients with bifurcation lesions underwent crush-stenting with the sirolimus-eluting
stent. Postintervention IVUS was performed in both branches in 25 lesions and only the main
vessel (MV) in 15 lesions; IVUS analysis included five distinct locations: MV proximal stent,
crush area, distal stent, SB ostium, and SB distal stent.
RESULTS Overall, the MV minimum stent area was larger than the SB (6.7  1.7 mm2 vs. 4.4  1.4
mm2, p 0.0001, respectively). When only the MV was considered, the minimum stent area
was found in the crush area (rather than the proximal or MV distal stent) in 56%. When both
the MV and the SB were considered, the minimum stent area was found at the SB ostium
in 68%. The MV minimum stent area measured 4 mm2 in 8% of lesions and 5 mm2 in
20%. For the SB, a minimum stent area 4 mm2 was found in 44%, and a minimum stent
area 5 mm2 in 76%, typically at the ostium. “Incomplete crushing”—incomplete apposition
of SB or MV stent struts against the MV wall proximal to the carina—was seen in 60% of
non-left main lesions.
CONCLUSIONS In the majority of bifurcation lesions treated with the crush technique, the smallest minimum
stent area appeared at the SB ostium. This may contribute to a higher restenosis rate at this
location. (J Am Coll Cardiol 2005;46:599–605) © 2005 by the American College of
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.05.034Cardiology Foundation
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lercutaneous coronary intervention (PCI) of bifurcation
esions is complex and challenging (1). Regardless of the
echnique, restenosis rates after bare metal stenting were
igh (40% to 60%), especially at the ostium of the side
ranch (SB) (1–3) where lesions frequently present with
egative remodeling after PCI and suboptimal angiographic
esults before PCI (1,4). With the advance of drug-eluting
tents, the “crush” technique has been proposed to treat
ifurcation lesions because of its predictability, high proce-
ure success rate, and full coverage of the SB ostium (5,6).
owever, case reports suggest that restenosis at the SB
stium continues to be a problem (7). Intravascular ultra-
ound (IVUS) studies have shown that stent dimensions are
mportant predictors of restenosis even with drug-eluting
From the *Cardiovascular Research Foundation and Columbia University Medical
enter, New York, New York; †Odense University Hospital, Odense, Denmark;
Lenox Hill Hospital, New York, New York; and §San Raffaele Hospital, Milan,
taly.t
Manuscript received December 16, 2004; revised manuscript received February 28,
005, accepted March 10, 2005.tents (8,9). However, there is little data on final stent
imensions in both branches after bifurcation lesion inter-
ention regardless of the approach. For this reason, we
eport the IVUS findings after crush-stenting of bifurcation
esions. It was our hypothesis that, regardless of the angio-
raphic result, imaging of both branches would reveal
nadequate stent expansion in at least one branch.
ETHODS
tudy population. Between April 2003 and May 2004, 40
atients with a single bifurcation lesion underwent success-
ul stenting using the crush technique and sirolimus-eluting
tents in both branches (Cypher, Cordis Corp., Miami
akes, Florida) and postintervention IVUS analysis. This
epresents 33% of patients with bifurcation lesions treated
ith the crush technique during this time period. Intravas-
ular ultrasound was performed in both branches in 25
esions and just the main vessel (MV) in 15 lesions. In 14 of
he 15 patients with just MV IVUS, there was no attempt to
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Crush Stenting for Bifurcation Lesions August 16, 2005:599–605mage the SB. We primarily report the findings in patients
ith IVUS of both branches. Written informed consent was
btained before all procedures. Clinical demographics were
btained by hospital chart review.
echnique. The crush stent technique has been reported in
etail elsewhere (5). In brief, both branches are wired and
referably predilated. The first stent is advanced into the
B, but not expanded, while a second stent is advanced into
he MV to cover fully the bifurcation. The SB stent is
etracted into the MV so that its proximal edge is 4 to 5 mm
roximal to the carina and then expanded. The SB stent
elivery balloon and guidewire are removed after a contrast
njection ensures that no distal dissection is present and no
dditional SB stents are needed. The MV stent is then
xpanded. In 23 of the 25 patients, the SB was rewired and
edilated with the kissing balloon technique regardless of
he angiographic appearance. Aspirin 325 mg and a 300-mg
oading dose of clopidogrel were administered preprocedure
nless patients were already pretreated. Glycoprotein IIb/
IIa inhibitors were given per operator discretion, and all
atients were prescribed aspirin (81 to 325 mg/day) indef-
nitely and clopidogrel (75 mg/day) for at least six months.
ngiographic analysis. Cineangiograms were indepen-
ently analyzed by the Cardiovascular Research Foundation’s
ngiographic Core Laboratory. Quantitative coronary angiog-
aphy (QCA) was performed using the CMS-GFT algorithm
MEDIS, Leesburg, Virginia). For the MV, the minimum
umen diameter (MLD) and the mean reference diameter
RD) (average of 5-mm segments proximal and distal to the
esion) were used to calculate the diameter stenosis: [DS  (1
MLD/RD)  100]. For the SB, the MLD and the distal
D were used to calculate DS. The MLD at the SB ostium
as also specifically measured.
VUS imaging and analysis. All IVUS studies were per-
ormed postintervention after intracoronary administration
f 100 to 200 g nitroglycerin using a commercially
vailable system (Boston Scientific, Natick, Massachusetts).
he 40-MHz IVUS catheter was advanced 10 mm
eyond the lesion, and an imaging run (using automated
ransducer pullback at 0.5 mm/s) was performed to a point
10 mm proximal to the lesion; IVUS imaging was
ecorded only during transducer pullback onto 0.5-inch
Abbreviations and Acronyms
CSA  cross-sectional area
DS  diameter stenosis
IVUS  intravascular ultrasound
LM  left main artery
MLD  minimum lumen diameter
MSA  minimum stent area
MV  main vessel
PCI  percutaneous coronary intervention
QCA  quantitative coronary angiography
SB  side branchigh-resolution s-VHS videotape for off-line analysis.
i
SQuantitative IVUS analysis was performed using com-
uterized planimetry (TapeMeasure, INDEC Systems,
ountain View, California) by an independent experienced
bserver blinded to the procedure and clinical data. Mea-
urements included stent and lumen cross-sectional areas
CSA). In the MV the proximal and distal references were
nalyzed; in the SB only the distal reference was analyzed.
he reference segments were the least-diseased image slices
largest lumen with least plaque), but within the same
egment. Stent CSA was assessed at five locations (Fig. 1):
V proximal stent: minimum stent CSA (MSA) between
the proximal MV stent edge and the crush area;
V crush area: MSA within the crush segment;
V distal stent: MSA between the crush area and the distal
edge of the MV stent;
B ostium: MSA 5 mm distal to the SB stent ostium;
B distal stent: MSA 5 mm distal to the SB stent ostium.
Stent expansion was defined as MSA divided by distal
eference lumen area.
tatistical analysis. Statistical analyses were performed
sing StatView 5.0 (SAS Institute, Cary, North Carolina).
ata are presented as mean  1 SD or frequencies. For
omparisons of categorical data, Fisher exact test was used.
or comparisons of two continuous variables, a two-tailed
npaired Student t test was used. Analysis of variance
ANOVA) was used for three subgroup comparison (prox-
mal stent vs. crush area vs. distal stent). Correlation of the
CA and IVUS MLD with regression lines was performed
sing Pearson correlation coefficient. A p value 0.05 was
onsidered significant.
igure 1. A schematic diagram of the in-stent segmental approach to
ntravascular ultrasound analysis after crush stenting. MV  main vessel;
B  side branch.
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aseline clinical characteristics are shown in Table 1.
ostintervention IVUS MLDs were smaller than QCA
n the MV (2.55  0.38 mm vs. 2.84  0.40 mm, p 
.001), but not in the SB (2.17  0.34 mm vs. 2.11 
.42 mm, p  0.58). However, there was only a moderate
orrelation between IVUS and QCA MLDs at both
ocations: MV (r  0.561, p  0.001) and SB (r  0.532,
 0.006) (Fig. 2).
on-left main artery (LM) bifurcation lesions with IVUS
f both vessels. Table 2 shows the procedural, QCA, and
VUS data. The SB ostium was predilated in 80%, and final
issing balloon inflations were performed in 90%. By QCA,
B lesions were shorter compared to MV lesions with
maller reference diameters and smaller pre- and postpro-
edure MLD.
Similar to QCA, IVUS showed smaller SB distal
eference measurements compared to the MV. Within
able 1. Baseline Characteristics
Variables n  25
ge, yrs 63.3  11.9
ale 68%
iabetes 32%
urrent smoker 44%
ypertension 68%
yperlipidemia 64%
rior myocardial infarction 28%
nstable angina 72%
ultivessel disease 68%
ype of bifurcation D/F* 68%/32%
ngle of origin of side branch, degrees 57.2  20.3
ain vessel/side branch
LAD/diagonal 72%
LCX/OM 8%
LAD/LCX (i.e., LM) 20%
alues are expressed as mean  SD (median) or frequencies (% of column total).
According to the Duke classification.
LAD  left anterior descending coronary artery; LCX  left circumflex coronary
rtery; LM  left main; OM  obtuse marginal branch.igure 2. Intravascular ultrasound (IVUS) minimum lumen diameter (MLD) v
left) and side branch (SB) ostium (right).he MV, there was no significant difference in stent CSA
omparing the proximal stent, crush area, and distal stent
p ANOVA  0.07). Within the SB there was no
ifference between the ostial and distal stent CSA (p 
.6). However, the SB MSA was smaller than the MV (p
0.0001); stent expansion was significantly less in the
B compared to the MV (p  0.02); 55% of SB stents
ad an MSA 4 mm2 (vs. 10% in the MV, p  0.007),
nd 90% of SB stents had an MSA 5 mm2 (vs. 20% in
he MV, p  0.006). Figure 3 shows an example of SB
tent underexpansion.
“Incomplete crushing”—defined as incomplete apposi-
ion of SB or MV stent struts against the MV wall proximal
o the carina (Fig. 4)—was seen in 60%. Incomplete
rushing was associated with SB underexpansion (77.1 
.6% vs. 89.4  13.1%, p  0.04), but there were no other
ifferences (Table 3).
The 15 patients with non-LM lesions and just MV IVUS
ere compared to patients with IVUS of both vessels. There
as no difference in QCA MV and SB lesion length (p 
.63 and p  0.62), reference diameter (p  0.11 and p 
.23), and poststent MLD (p  0.12 and p  0.73). There
as no difference in IVUS MV stent CSA (p  0.31) and
xpansion (p  0.32) or frequency of incomplete crush
64%).
M (left anterior descending coronary artery/left circumflex
rtery) bifurcation lesions with IVUS of both vessels. Table
shows the procedural, QCA, and IVUS data. The SB
stium (left circumflex artery) was predilated in four of five
ases (80%), and final kissing balloon inflations were per-
ormed in all cases.
Intravascular ultrasound MV imaging showed a signifi-
ant difference in stent CSA comparing the proximal stent,
rush area, and distal stent (p ANOVA  0.007); the
roximal stent CSA was significantly larger than both the
rush stent CSA (p  0.004) and the distal stent CSA (p 
.004). In the SB, however, the ostial and distal stent CSA
ere similar (p  0.45) as was stent expansion (p  0.31).ersus quantitative coronary angiography (QCA) MLD in the main vessel
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Crush Stenting for Bifurcation Lesions August 16, 2005:599–605nly one MV lesion and one SB lesion had an MSA 5
m2 with none4.0 mm2. Incomplete crush was not found
n these lesions.
ummary analysis. Overall, mostly driven by non-LM
esions, the MV MSA (6.7  1.7 mm2) was larger than the
B (4.4  1.4 mm2, p  0.0001). The results were similar
mong the different operators. When only the MV was
onsidered, the MSA was found in the crush area (rather
han the proximal or distal stent) in 56%. When both the
V and the SB were considered, the MSA was found at the
B ostium in 68%. The MV MSA measured4 mm2 in 8%
f lesions and 5 mm2 in 20% of lesions. For the SB an
SA4 mm2 was found in 44%, and an MSA5 mm2 in
6%.
Incomplete apposition of MV stent struts to the vessel
all (in addition to incomplete crush of the SB stent struts)
as found in five patients: four in the proximal end of the
tent and two in the distal end of the stent (one patient had
ncomplete apposition at both locations). The only patient
able 2. Procedural, QCA, and IVUS Data for Non-LM
esions With IVUS of Both Branches (n  20)
Variables Main Vessel Side Branch p Value
rocedure
Predilation balloon, mm 2.6  0.3 2.5  0.3 0.35
Stent diameter, mm 3.2  0.8 2.8  0.7 0.15
Stent length, mm 22.5  7.3 18.5  7.3 0.24
Final balloon, mm 3.2  1.0 2.8  0.3 0.07
Final pressure, atm 14.6  3.9 14.8  5.3 0.90
ngiography
Preprocedure
Lesion length, mm 18.95  9.21 12.32  7.21 0.02
Reference diameter, mm 2.90  0.34 2.32  0.20 0.0001
MLD, mm 1.00  0.33 0.73  0.26 0.007
%DS 65.6  9.3 68.5  10.5 0.34
Final
Reference diameter, mm 3.01  0.35 2.41  0.22 0.0001
Stent MLD, mm 2.91  0.38 2.16  0.35 0.0001
SB ostium MLD, mm — 2.22  0.42 N/A
Stent %DS 3.3  6.2 10.3  13.2 0.04
Balloon/artery ratio 1.21  0.10 1.25  0.13 0.28
VUS
Proximal reference lumen
CSA, mm2
9.0  4.9 — N/A
Distal reference lumen
CSA, mm2
7.2  3.2 5.2  2.5 0.06
MSA, mm2 6.5  1.7 3.9  1.0 0.0001
Proximal MV MSA, mm2 8.1  3.2 — N/A
Crush MSA, mm2 6.7  2.3 — N/A
Crush length, mm 5.0  2.0 — N/A
Distal MSA, mm2 7.0  2.8 4.5  2.3 0.004
SB ostium MSA, mm2 — 4.2  1.0 N/A
Stent expansion, % 92.1  16.6 79.9  12.3 0.02
Stent CSA 4 mm2 10% (2/20) 55% (11/20) 0.007
Stent CSA 5 mm2 20% (4/20) 90% (18/20) 0.006
alues are expressed as mean  SD (median) or frequencies (% of column total). For
omparisons of continuous variables, a two-tailed unpaired Student t test was used; for
omparisons of categorical data, Fisher exact test was performed.
CSA  cross-sectional area; DS  diameter stenosis; IVUS  intravascular ultra-
ound; LM  left main; MLD  minimum lumen diameter; MSA  minimum stent
rea; MV  main vessel; QCA  quantitative coronary angiography; SB  side branch.ith subacute stent thrombosis had incomplete crushing. phere was no incomplete SB stent apposition. Incomplete
rush was associated with smaller MV nominal balloon sizes
3.06  1.07 mm vs. 3.33  0.26 mm, p  0.67) and
maller summed (MV  SB) nominal balloon sizes (5.50 
.92 mm vs. 6.08  0.37 mm, p  0.17), but no difference
n SB nominal balloon sizes or QCA MLD in the MV
r SB.
ISCUSSION
ostprocedure analysis of bifurcation lesions treated with
he crush-stent technique with IVUS imaging of both
essels showed: 1) the MSA was smaller in the SB than the
V; 2) the majority of SB lesions showed stent underex-
ansion with the smallest MSA typically found at the SB
stium; 3) stent underexpansion detected by IVUS was not
uspected angiographically; and 4) incomplete stent appo-
ition in the crush area was common. These findings have
mplications regarding the mechanism and frequency of
estenosis after bifurcation stenting using either bare metal
r drug-eluting stents.
auses of in-stent restenosis. In-stent restenosis can be
aused by chronic stent recoil (very rare), chronic stent
nderexpansion, and/or intimal hyperplasia (7,10). How-
ver, serial IVUS studies delineating these mechanisms did
ot include bifurcation lesions. Therefore, chronic stent
ecoil cannot be excluded at this location, especially because
his location has unusual geometry and (potentially) greater
xternal constrictive forces. Serial IVUS study of both
ranches at implantation and follow-up would be required
o exclude chronic bifurcation stent recoil. Such a study has
ot been done. In fact, the current report is rare in that it
ncludes 25 of bifurcation stented lesions in which both
ranches were imaged even at a single point in time, in this
ase, postimplantation.
In the bare-metal stent era, stenting both branches of a
ifurcation increased the risk of restenosis compared to only
tenting the MV (1–3). However, imaging of the SB was
ot performed consistently after stent implantation. There-
ore, as shown in the current analysis, the impact of SB stent
nderexpansion may have been underappreciated, even in
atients with good angiographic results of both branches.
hus, angiography appears to have a limited ability to detect
nderexpanded bifurcation stents.
Ostial SB stent underexpansion may be the dominant
echanism of restenosis with drug-eluting stents because
ven a small amount of intimal hyperplasia superimposed on
ignificant stent underexpansion can result in restenosis. A
ew reports of bifurcation lesions treated with two drug-
luting stents still indicate a relatively high incidence of
estenosis, and the site of restenosis is systematically at the
B ostium regardless of the technique—T-stenting, modi-
ed T-, Y-, or V-stenting (7,11,12). It is not clear whether
ifurcation lesions are associated with more intimal hyper-
lasia compared to nonbifurcations.
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August 16, 2005:599–605 Crush Stenting for Bifurcation LesionsIn the IVUS substudy of the Sirolimus-Eluting Stent
ersus Standard Stents in Patients With Stenosis in Native
oronary Artery (SIRIUS) trial, MSA 5 mm2 for the
otal cohort and MSA 4.5 mm2 for vessels 2.8 mm by
CA were thresholds that predicted an “adequate” IVUS
umen at follow-up (9). The positive predictive value of the
VUS stent dimensions was 90%. This was not surprising;
nce an effective drug (in this case sirolimus) inhibited most
f the intimal hyperplasia, the main cause of in-stent
estenosis became stent underexpansion. In our group of
on-LM bifurcation lesions, MSA 5.0 mm2 was found in
0% of lesions (mostly the SB stent ostium), and MSA
4.5 mm2 was found in 69% of stents with an mean
eference diameter 2.8 mm (again, mostly the SB stent
stium). Thus, our bifurcation lesions frequently had an
igure 3. (A, B) Preprocedure angiograms showing a “true bifurcation” lesio
ranch in the cranial and left anterior oblique (LAO) views, respectively. (C
t the bifurcation lesion (cranial and LAO views, respectively). (E) Intravas
iagonal) stent. (F) Intravascular ultrasound of the SB ostium showing stSA below the threshold associated with restenosis. tThe crush technique was developed to overcome two
otential problems with bifurcation stenting: stent under-
xpansion and incomplete coverage of the SB ostium. In the
urrent study, the MSA at the SB was 3.9 mm2 in non-LM
esions and 6.1 mm2 in LM lesions. In addition, the MSA
as found at the SB ostium in 13 of 20 non-LM lesions
nd 4 of 5 LM lesions. Regardless of predilation of the
B ostium (80% of cases) and final kissing balloon
nflations (all but two cases), IVUS imaging confirmed
hat the crush technique is still associated with SB stent
nderexpansion, especially at the SB ostium. Further-
ore, the current study found incomplete crushing (i.e.,
ncomplete apposition) of the stents against the MV wall
roximal to the carina in the majority of cases. This has
een reported by others (13) and may affect drug delivery,
e D) in the proximal left anterior descending coronary artery/first diagonal
Final angiograms showing optimal angiographic result after crush-stenting
ultrasound image showing the distal portion of the side branch (SB) (first
derexpansion. MV  main vessel.n (typ
, D)
cularhereby contributing to restenosis.
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Crush Stenting for Bifurcation Lesions August 16, 2005:599–605tudy limitations. Only 25 of 40 patients had final IVUS
n both branches. However, QCA showed no difference
etween patients with IVUS of both branches versus IVUS
f just the main branch. This study includes only patients
ith a successful procedure (Thrombolysis In Myocardial
nfarction flow grade 3 and final DS 30% in both
ranches and no complications); however, this only high-
igure 4. (A) Intravascular ultrasound image showing complete crush (app
truts. (B, C) Intravascular ultrasound images showing incomplete crush (
able 3. Comparison Between IC Versus CC in Patients With N
Variables
MV
IC C
rocedure
Predilation balloon, mm 2.4  1.3 2.7
Stent diameter, mm 3.1  1.1 3.3
Stent length, mm 19.9  8.6 23.8
Final balloon, mm 3.1  1.1 3.3
Final pressure, atm 15.3  5.5 15.3
ngiography
Preprocedure
Lesion length, mm 17.96  5.40 19.13
Reference diameter, mm 2.85  0.27 2.96
MLD, mm 1.05  0.52 0.85
%DS 63.7  16.6 72.5
Final
Reference diameter, mm 2.92  0.23 3.08
Stent MLD, mm 2.81  0.30 2.85
SB ostium MLD, mm — —
Stent %DS 3.8  7.8 7.2
Balloon/artery ratio 1.13  0.14 1.09
VUS
Proximal reference lumen CSA, mm2 8.4  4.0 7.0
Distal reference lumen CSA, mm2 7.2  3.4 6.9
MSA, mm2 6.3  1.7 6.8
Proximal MV MSA, mm2 7.6  2.0 8.5
Crush MSA, mm2 6.3  1.7 6.9
Crush length, mm 5.5  1.2 4.6
Distal MSA, mm2 6.4  3.2 7.4
SB ostium MSA, mm2 — —
Stent expansion, % 85.6  19.7 98.0
Stent CSA 4 mm2 8.3% (1/12) 12.5%
Stent CSA 5 mm2 16.7% (2/12) 25%
alues are expressed as mean  SD (median) or frequencies (% of column total). F
omparisons of categorical data, Fisher exact test was performed.CC  complete crush; CSA  cross-sectional area; DS  diameter stenosis; IC  incom
SA  minimum stent area; MV  main vessel; SB  side branch.ights the current findings. Predilation plus final kissing
alloon inflations were performed in 76% of patients;
herefore, it was not possible to assess the impact of these
rocedural steps.
onclusions and clinical implications. In the majority of
ifurcation lesions treated with the crush technique, the
SA appeared at the SB ostium where the stent CSA is
n) of the side branch (SB) stent; arrows indicate the three layers of stent
ition) of the SB stent struts (arrows).
eft Main Lesions and IVUS of Both Branches
p Value
SB
p ValueIC CC
0.66 2.3  1.2 2.8  0.3 0.34
0.67 2.8  1.0 2.8  0.3 1.0
0.32 21.1  7.9 18.0  7.1 0.45
0.67 2.8  1.3 2.8  0.3 1.0
1.0 14.1  6.4 15.7  4.1 0.60
7 0.58 10.21  2.15 14.14  5.79 0.16
6 0.49 2.43  0.40 2.21  0.30 0.28
7 0.49 0.73  0.38 0.46  0.33 0.19
7 0.33 70.6  13.2 80.3  11.7 0.17
2 0.28 2.49  0.36 2.37  0.31 0.52
9 0.78 2.22  0.61 2.09  0.51 0.68
— 2.28  0.61 2.06  0.52 0.48
0.41 10.0  22.1 12.4  14.6 0.82
7 0.67 1.20  0.14 1.22  0.30 0.90
0.50 — — —
0.87 5.3  2.6 4.9  2.6 0.77
0.62 3.9  0.9 4.1  1.3 0.73
0.59 — — —
0.56 — — —
0.36 — — —
0.52 4.3  2.4 4.7  1.4 0.72
— 4.2  0.8 4.3  1.6 0.87
6 0.28 77.1  7.6 89.4  13.1 0.04
) 0.65 58.3% (7/12) 50.0% (4/8) 0.93
) 0.91 92% (11/12) 87.5% (7/8) 0.65
parisons of continuous variables, a two-tailed unpaired Student t test was used; forositioon-L
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August 16, 2005:599–605 Crush Stenting for Bifurcation Lesionsrequently below the cutoff that has been associated with a
ow rate of restenosis. As a result, stent underexpansion may
ontribute to the higher reported restenosis rate at this
ocation. In the bare metal stent era, the goal was to
ptimize the MV intervention and achieve an adequate
esult in the SB without compromising the MV. In the
able 4. Procedural, QCA, and IVUS Data LM Lesions With
VUS of Both Branches (n  5)
Variables MV SB p Value
rocedure
Predilation balloon, mm 2.9  0.4 3.2  0.5 0.35
Stent diameter, mm 3.3  0.3 3.4  0.2 0.54
Stent length, mm 23.0  5.0 19.8  7.8 0.46
Final balloon, mm 3.8  0.7 3.4  0.4 0.29
Final pressure, atm 14.8  5.0 15.6  1.7 0.74
ngiography
Preprocedure
Lesion length, mm 15.93  5.93 13.64  2.05 0.44
Reference diameter, mm 2.97  0.55 2.97  0.21 1.0
MLD, mm 1.01  0.40 0.90  0.33 0.65
%DS 66.9  8.3 70.2  10.0 0.59
Final
Reference diameter, mm 3.30  0.45 3.16  0.16 0.53
Stent MLD, mm 3.20  0.37 2.89  0.19 0.13
SB ostium MLD, mm — 3.17  0.36 N/A
Stent %DS 2.8  5.4 8.0  10.2 0.34
Balloon/artery ratio 1.18  0.09 1.12  0.05 0.23
VUS
Proximal reference
lumen CSA, mm2
16.5  7.4 — N/A
Distal reference lumen
CSA, mm2
8.6  1.7 8.5  1.7 0.93
MSA, mm2 7.4  1.6 6.1  1.6 0.23
Proximal MV MSA,
mm2
13.4  7.3 — N/A
Crush MSA, mm2 8.2  2.0 — N/A
Crush length, mm 4.9  2.8 — N/A
Distal MSA, mm2 8.2  1.4 6.9  0.4 0.09
SB ostium MSA, mm2 — 6.1  1.6 N/A
Stent expansion, % 88.2  20.1 70.2  22.9 0.22
Stent CSA 4 mm2 0% (0/5) 0% (0/5) N/A
Stent CSA 5 mm2 20% (1/5) 20% (1/5) 1.0
alues are expressed as mean  SD (median) or frequencies (% of column total). For
omparisons of continuous variables, a two-tailed unpaired Student t test was used; for
omparisons of categorical data, Fisher exact test was performed.
CSA  cross-sectional area; DS  diameter stenosis; IVUS  intravascular
ltrasound; LM  left main; MLD  minimum lumen diameter; MSA  minimum
tent area; MV main vessel; QCA quantitative coronary angiography; SB side
ranch.he result in the SB. The fact that the stent-crush technique
even completed with kissing balloon inflation) leaves small
stial SB lumen diameters and frequent poor MV wall
pposition (incomplete crushing) fits well with the reported
ncidence of high SB ostial recurrence. This should be
actored into strategies for bifurcation lesions.
eprint requests and correspondence: Dr. Stephane Carlier,
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